VISTN — Vistin Pharma ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Vistin Pharma ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	—	—	—	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	320	77	35.7	1.44	26.2
Net Total Accounts Receivable
Net Total Receivables	48.9	32.7	43.1	71.2	57.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	395	142	138	159	164
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	102	145	167	219	220
Other Long Term Assets
Total Assets	504	322	333	407	399
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.2	32.2	41	118	64.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	90.8	49.5	57.4	134	75.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	413	272	276	273	323
Total Liabilities & Shareholders' Equity	504	322	333	407	399
Total Common Shares Outstanding